427 related articles for article (PubMed ID: 26162472)
1. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
3. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.
Iatta R; Immediato D; Montagna MT; Otranto D; Cafarchia C
Med Mycol; 2015 Apr; 53(3):269-74. PubMed ID: 25631480
[TBL] [Abstract][Full Text] [Related]
6. High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
Kano R; Aramaki C; Murayama N; Mori Y; Yamagishi K; Yokoi S; Kamata H
Med Mycol; 2020 Feb; 58(2):197-200. PubMed ID: 31329927
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and genetic diversity of azole-resistant Malassezia pachydermatis isolates from canine otitis and dermatitis: A 2-year study.
Álvarez-Pérez S; Quevedo-Caraballo S; García ME; Blanco JL
Med Mycol; 2024 May; 62(5):. PubMed ID: 38734886
[TBL] [Abstract][Full Text] [Related]
8. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis.
Prado MR; Brito EH; Brilhante RS; Cordeiro RA; Leite JJ; Sidrim JJ; Rocha MF
J Microbiol Methods; 2008 Oct; 75(2):341-3. PubMed ID: 18603321
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.
Cafarchia C; Figueredo LA; Favuzzi V; Surico MR; Colao V; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Oct; 159(3-4):536-40. PubMed ID: 22622336
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
[TBL] [Abstract][Full Text] [Related]
12. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
[TBL] [Abstract][Full Text] [Related]
13. Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin.
Yurayart C; Nuchnoul N; Moolkum P; Jirasuksiri S; Niyomtham W; Chindamporn A; Kajiwara S; Prapasarakul N
Med Mycol; 2013 Oct; 51(7):721-30. PubMed ID: 23547880
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility of Malassezia pachydermatis biofilm.
Figueredo LA; Cafarchia C; Otranto D
Med Mycol; 2013 Nov; 51(8):863-7. PubMed ID: 23834283
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of amphotericin B-azole combinations against Malassezia pachydermatis strains.
Álvarez-Pérez S; García ME; Blanco JL
Med Mycol; 2019 Feb; 57(2):196-203. PubMed ID: 29534201
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Azole and Amphotericin B Susceptibilities of
Rhimi W; Inyang Aneke C; Mosca A; Otranto D; Cafarchia C
Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32604712
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections.
Iatta R; Figueredo LA; Montagna MT; Otranto D; Cafarchia C
J Med Microbiol; 2014 Nov; 63(Pt 11):1467-1473. PubMed ID: 25168965
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
20. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
